TD Cowen Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $108

Benzinga Newsdesk www.benzinga.com Negative 57.7%

Neg 57.7% Neu 0% Pos 0%

TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $110 to $108.